Form 4: GE HealthCare Director Anne T. Madden Boosts Stake with Equity Awards

GE HealthCare Technologies Inc. Director Anne T. Madden reported the acquisition of restricted stock units and deferred stock units as part of her compensation, increasing her beneficial ownership to 13,611 shares.

Summary

• Anne T. Madden, a Director of GE HealthCare Technologies Inc. (GEHC), reported changes in her beneficial ownership of the company's common stock.
• On May 28, 2025, Ms. Madden was awarded 3,092 restricted stock units (RSUs) at a price of $0 per unit.
• These RSUs are set to vest 100% on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026.
• Additionally, on May 28, 2025, Ms. Madden received an award of 1,756 fully vested deferred stock units (DSUs) at a price of $0 per unit.
• The DSUs were elected by Ms. Madden in lieu of 100% of her cash retainer, in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.
• Each restricted stock unit and deferred stock unit represents the right to receive one share of GE HealthCare common stock upon settlement.
• Following these transactions, Anne T. Madden's direct beneficial ownership of GE HealthCare common stock increased to 13,611 shares.

Sentiment

Score: 7

Explanation: The filing indicates a standard equity compensation award to a director, which is positive for aligning interests and is a routine corporate governance practice. It does not, however, provide direct insight into the company's operational or financial performance.

Positives

• The acquisition of equity awards by a director aligns their interests with those of the shareholders, promoting long-term value creation.
• The election to receive deferred stock units in lieu of cash retainer demonstrates confidence in the company's future performance by the director.

Future Outlook

The restricted stock units awarded are scheduled to vest on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026. Settlement of both vested restricted stock units and deferred stock units may be deferred by the reporting person according to their deferral election under the company's plan.

Management Comments

• The awards were made in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the 'Plan').
• The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded.

Industry Context

This filing reflects a common practice in corporate governance where non-employee directors receive a portion of their compensation in the form of equity (such as RSUs and DSUs) to align their financial interests with the long-term performance of the company and its shareholders. This is a standard component of compensation packages for directors in publicly traded companies, particularly in the healthcare technology sector.

Comparison to Industry Standards

• The practice of compensating non-employee directors with equity awards, such as restricted stock units and deferred stock units, is a widely adopted standard across industries, including healthcare technology.
• Many companies, including peers like Siemens Healthineers AG or Philips N.V., utilize similar equity-based compensation structures for their non-executive board members to foster alignment with shareholder interests.
• The election to receive deferred stock units in lieu of cash is also a common option offered to directors, allowing for tax deferral and further commitment to the company's stock performance.

Corporate Governance

Related Party Transactions

• The transaction involves the company (GE HealthCare Technologies Inc.) granting equity awards to a director (Anne T. Madden), which is a standard related-party compensation arrangement.

Stakeholder Impact

• Shareholders: The equity awards align the director's financial interests with shareholder value, potentially leading to more shareholder-centric decision-making.
• Employees: No direct impact mentioned, but a well-governed company with aligned leadership can indirectly benefit all employees.

Next Steps

• Vesting of the 3,092 restricted stock units on the earlier of GE HealthCare's next annual meeting or May 28, 2026.
• Potential settlement of vested restricted stock units and deferred stock units based on the reporting person's deferral election.

Key Dates

Keywords

GE HealthCare Technologies, GEHC, Form 4, Insider Transaction, Beneficial Ownership, Restricted Stock Units, Deferred Stock Units, Equity Compensation, Director Compensation, SEC Filing